BMAN72201 Assessed Coursework Feedback Sheet 2014-15 This sheet provides feedback on your work, with comments used where appropriate to identify particular areas of strength and weakness.
Student registration number______9538546______________________________________ Company selected ___________Sanofi / Genzyme_________________________________

Area/Issue
Introduction and set-up Conclusion and overall answer to the question Development of the argument (including critical analysis of business model concept; understanding of the specific deal chosen)

Comments
Good, clear introduction Concise conclusion provides an overview of the deal – what about the Q ie the usefulness of the BM approach. A brief overview of some approaches to BM. You provide a clear statement about how you intend to use the concept. In practice, this gets a bit confused later as you don’t follow through in an entirely coherent way. Try to keep focused on the idea of the BM. You discuss Sanofi’s BM in various ways to explain basic principles and how things have been changing. What is a ‘more diversified and continuous’ BM (p.4) can you explain this a bit more to help introduce the Genzyme deal. You outline various explanations for the deal, include the specific problems of Sanofi – these points are very nicely developed. Generally very clearly written. Your analysis is precise and authoritative. Some useful charts. Figure 3 seems to be missing. You could look at Sanofi’s performance in a bit more detail eg growth rates, margins, shareholder returns ie what was happening to viability and credibility in the run up to the deal? Generally you have a good analytical style, incorporating evidence into your argument. You could draw more widely on other commentaries about the deal eg analysts – to note what they like and/or dislike. Is it all a good new story or are there concerns? – this would help with critical analysis of the deal.

Structure, writing style and presentation (including clarity, precision, readable style, clear presentation) General argument and use of financial and other evidence (including deployment and relevance of evidence; avoidance of unsupported claims and assertions; emphasis on analytical rather than descriptive material; original/creative use of materials; integration of financial analysis, effective use of graphs, tables etc) Research and use of literature and sources: (including range of sources used, acknowledgement of sources, referencing, demonstrated skills in use of information) Other comments

Mark awarded (max 100%) (subject to confirmation by external examiner) Penalties due to late submission, over-length etc (if applicable) Adjusted mark, where relevant

66